Ftse Mib
33.220,31
-0,29%
DAX
18.067,91
-0,31%
S&P 500
5.487,03
0,25%
NASDAQ
17.862,23
0,03%
Bitcoin
65.145,66
0,27%
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adial Pharmaceuticals Inc (ADIL) Adial Pharmaceuticals Inc (ADIL) Notizie

Adial Pharmaceuticals Inc

ADIL
1,27
-0,01 (-0,78%)
19 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
05/6/202414:30GLOBEAdial Pharmaceuticals Achieves Important Milestone of First..
29/5/202414:30GLOBEAdial CEO to Present at the Spring MicroCap Rodeo Conference..
15/5/202414:30GLOBEAdial Pharmaceuticals Reports First Quarter 2024 Financial..
14/5/202423:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/4/202414:30GLOBEAdial Pharmaceuticals Granted Key Patent from the United..
10/4/202414:30GLOBEAdial Pharmaceuticals Announces Peer-Reviewed Publication..
02/4/202414:30GLOBEAdial Pharmaceuticals Reports 2023 Fiscal Year Financial..
02/3/202401:00GLOBEAdial Pharmaceuticals Announces Exercise of Warrants for..
28/2/202415:30GLOBEAdial Pharmaceuticals Awarded New Patent from the United..
14/2/202421:22EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/2/202415:15GLOBEAdial Pharmaceuticals Awarded New Patent Notice of Allowance..
25/1/202422:30EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/1/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
18/1/202422:15EDGAR2Form 8-K - Current report
18/1/202414:30GLOBEAdial Announces Appointment of Tony Goodman as Chief..
16/1/202422:17EDGAR2Form 8-K - Current report
12/1/202422:51EDGAR2Form S-3 - Registration statement under Securities Act of..
20/12/202315:00GLOBEAdial Pharmaceuticals Receives Final Reimbursement Payment..
12/12/202322:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/12/202317:08EDGAR2Form DEF 14A - Other definitive proxy statements
29/11/202322:47EDGAR2Form 8-K - Current report
29/11/202322:05GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
28/11/202322:10EDGAR2Form 8-K - Current report
24/11/202315:24EDGAR2Form PRE 14A - Other preliminary proxy statements
20/11/202313:46EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/11/202323:02GLOBEAdial Pharmaceuticals Reports Third Quarter 2023 Financial..
08/11/202322:05EDGAR2Form S-1 - General form for registration of securities under..
06/11/202312:14EDGAR2Form 8-K - Current report
31/10/202313:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
30/10/202322:24EDGAR2Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]:..
30/10/202322:18EDGAR2Form 8-K/A - Current report: [Amend]
30/10/202322:17EDGAR2Form NT 10-Q/A - Notification of inability to timely file..
25/10/202314:00GLOBEAddiction Experts Highlight the Need for..
24/10/202322:48EDGAR2Form 8-K - Current report
24/10/202322:30GLOBEAdial Pharmaceuticals Announces Closing of $4 Million..
20/10/202314:00GLOBEAdial Pharmaceuticals Announces $4 Million Private Placement..
19/10/202316:30GLOBEAdial Pharmaceuticals Awarded Notice of Allowance for Key..
18/10/202314:00GLOBEAdial Pharmaceuticals Wins Frost & Sullivan's 2023 North..
03/10/202314:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/9/202313:00GLOBEAdial Pharmaceuticals to Host a Virtual Key Opinion Leader..
27/9/202303:08EDGAR2Form 8-K - Current report
21/9/202322:10EDGAR2Form 8-K - Current report
11/9/202312:03EDGAR2Form 8-K - Current report
05/9/202314:30GLOBEAdial Pharmaceuticals to Present at the H.C. Wainwright 25th..
28/8/202314:30GLOBEAdial Pharmaceuticals Chief Medical Officer and Key Opinion..
23/8/202314:45EDGAR2Form 8-K - Current report
23/8/202314:30GLOBEAdial Pharmaceuticals Regains Compliance with Nasdaq Listing..
21/8/202314:46EDGAR2Form 8-K - Current report
21/8/202314:30GLOBEAdial Pharmaceuticals Reports Second Quarter 2023 Financial..
21/8/202314:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: 1,29 Min: 1,24 Max: 1,33
Chiusura: 1,28

La tua Cronologia

NASDAQ
ADIL
Adial Pharmaceuticals
EU
ALHYP
Hipay
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network